%PDF-1.4
%
52 0 obj
<>
endobj
49 0 obj
<>
endobj
107 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-01-10T11:30:39Z
2024-03-28T13:43:31-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T13:43:31-07:00
application/pdf
Heather
2004-180.feb
uuid:bbdb6334-1dd1-11b2-0a00-3d09275dc400
uuid:bbdb6337-1dd1-11b2-0a00-810000000000
endstream
endobj
38 0 obj
<>
endobj
39 0 obj
<>
endobj
53 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 24 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 26 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 28 0 R/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
125 0 obj
[129 0 R]
endobj
126 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 73.868 737.0293 Tm
[(rheumatoid arthritis in southern Chinese. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw 0 -1.25 TD
(2000;43:1679-87.)Tj
-0.00011 Tc 0.00729 Tw -2.175 -1.25 Td
[(20.)-875.1 (Saevarsdottir )-17.7 (S, V)59.8 (ikingsdottir T)74 (,)-0.1 ( V)59.8 (ikingsson )37.1 (A, )-17.7 (Manfredsdottir V)128.9 (,)]TJ
0.02499 Tw 2.175 -1.25 Td
[(Geirsson )54.8 (AJ, )17.7 (V)110.8 (aldimarsson H. Low mannose binding lectin predicts)]TJ
T*
[(poor prognosis in patients with early rheumatoid arthritis. )54.8 (A)]TJ
T*
[(prospective study)64.8 (. J Rheumatol 2000;28:728-34.)]TJ
-2.175 -1.25 Td
[(21.)-875.1 (Ogden CA, deCathelineau )54.8 (A, Hof)17.7 (fmann PR, et al. C1q and )]TJ
2.175 -1.25 Td
(mannose-binding lectin engagement of cell surface calreticulin and)Tj
T*
(CD91 initiates macropinocytosis and uptake of apoptotic cells. )Tj
0 Tc T*
(J Exp Med 2001;194:781-95.)Tj
-0.00011 Tc 30.8875 11.25 Td
[(22.)-875.1 (Nauta )54.8 (AJ, Raaschoti-Jensen N, Roos )54.8 (A, et al. Mannose-binding)]TJ
2.175 -1.25 Td
(lectin engagement with late apoptotic and necrotic cells. Eur )Tj
T*
(J Immunol 2003;33:2853-63.)Tj
-2.175 -1.25 Td
[(23.)-875.1 (Nauta )54.8 (AJ, Daha MR, Kooten C, Roos )54.8 (A. Recognition and clearance)]TJ
2.175 -1.25 Td
[(of apoptotic cells: a role for complement and pentraxins. )17.7 (T)35 (rends)]TJ
T*
(Immunol 2003;24:148-54. )Tj
-2.175 -1.25 Td
[(24.)-875.1 (Sakane )17.7 (T)74 (,)-0.1 ( )17.7 (T)69.9 (akeno M, Suzuki N, Inaba G. Beh\215et\325)54.8 (s disease. N Engl J)]TJ
0 Tc 2.175 -1.25 Td
(Med 1999;341:1284-91.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(25.)-875.1 (Scully C, Gorsky M, Lozade-Nur F)79.7 (.)-0.1 ( )17.7 (The diagnosis and management)]TJ
2.175 -1.25 Td
[(of recurrent apthous stomatitis: a consensus approach. J )54.8 (Am Dent)]TJ
0 Tc T*
(Assoc 2003;134:200-7.)Tj
ET
0 0 0 1 K
53.468 76.5 m
558.468 76.5 l
S
0 0 0 0 k
494.29 69.365 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
0 Tw 8 0 0 8 545.468 56.4344 Tm
(291)Tj
ET
0 0 0 0 k
53.532 70.409 203 -16.571 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.532 56.5725 Tm
[(Inanc, et al: MBL)-257.3 (levels in BD)]TJ
ET
0 0 0 0 k
/GS0 gs
102.631 81.583 407.5 -10.833 re
f*
0.5 w
/GS1 gs
102.631 81.583 407.5 -10.833 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
32 0 obj
<>stream
8;Z\r;%eL($q0jh(X.$%A4+-]<1NO.maG2a8?uB--@Q=>b0@EUGplVTM47jRANQ49Wu
CeG'6BNLX_BGK?&FM0QV>-E>b[#-oG:8UPL:IIbID9S9M4N@a)6N17IbmW.NB]bsf
YQ/P^UC]`t+bUCn#U+j46L4db(hS%uI[;Yh1YI%*Md,X?r!BP-!%6T.i;~>
endstream
endobj
36 0 obj
[/Indexed/DeviceRGB 255 35 0 R]
endobj
35 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
64 0 obj
<>
endobj
59 0 obj
<>
endobj
96 0 obj
<>
endobj
112 0 obj
<>
endobj
58 0 obj
<>
endobj
89 0 obj
<>stream
H{PSrCPϋ@Z5"VYQQ.<"D $<gXP@@d*Ve2n7{iNΙΙ~s98fj8n{o_U!_f4:Q>gYb¸bS(Uİ)ja"H_%%.Xu`$Z^pw_sw!J Rzeou6~z}Mw(OI|ޕ+'R~Z̗i MKq|a-:BDRY2IG'ŭiN# ?~}7.YbXa l3},|{acqzVc7%GML&3xnm䑅LCl/jV-]н^(\sEV4ŜÜkΖmVV֭6Av*zmϳ^gq"(8Mh͑ 1)112Z3Z
Z
ᰮr|u
|eV)ԲLJlB,lİ:m
(u<}P(҂rrd>':d
;
ܾ??v~N}9L?% g4_(6**J3R.̔d*사Bˑ@qh
RB
CǽH֦ӵDTg&A-Ɇ
JŇgA
Nz \$
OܬۆS҆e|;7+z[L{
;ٝԭJq3F)ǂRT*ZՋ&qvlW?.h9pi7r`8)C `P-=MES%i2 $Q'